Selected research
Industry Research
Advanced Therapeutics Pharmaceutical Outsourcing Industry Research Report 2026
Market perspective
The global Advanced Therapeutics Pharmaceutical Outsourcing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Advanced Therapeutics Pharmaceutical Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Advanced Therapeutics Pharmaceutical Outsourcing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Advanced Therapeutics Pharmaceutical Outsourcing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Advanced Therapeutics Pharmaceutical Outsourcing include Croda International Plc, Charles River Laboratories International, Inc., Catalent, Inc., QuintileslMS (IQVIA), Parexel International Corporation, ICON plc, PPD, Inc. (Thermo Fisher Scientific), LabCorp (Laboratory Corporation of America Holdings) and Syneos Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Advanced Therapeutics Pharmaceutical Outsourcing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Advanced Therapeutics Pharmaceutical Outsourcing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Advanced Therapeutics Pharmaceutical Outsourcing Market by Company
Croda International Plc
Charles River Laboratories International, Inc.
Catalent, Inc.
QuintileslMS (IQVIA)
Parexel International Corporation
ICON plc
PPD, Inc. (Thermo Fisher Scientific)
LabCorp (Laboratory Corporation of America Holdings)
Syneos Health
wuXi AppTecLonza Group
Piramal Pharma Solutions
SGS SA
Evotec SE
CMC Biologics (Now AGC Biologics)
Marken (A UPS Company)
Cytovance Biologics
Samsung Biologics
Advanced Therapeutics Pharmaceutical Outsourcing Segment by Type
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
Advanced Therapeutics Pharmaceutical Outsourcing Segment by Application
Preclinical Services
Clinical Services
Commercial Manufacturing and Packaging
Advanced Therapeutics Pharmaceutical Outsourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapeutics Pharmaceutical Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapeutics Pharmaceutical Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapeutics Pharmaceutical Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Advanced Therapeutics Pharmaceutical Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Contract Research Organizations (CROs)
- Contract Development and Manufacturing Organizations (CDMOs)
Applications
- Preclinical Services
- Clinical Services
- Commercial Manufacturing and Packaging
Companies covered
- Croda International Plc
- Charles River Laboratories International, Inc.
- Catalent, Inc.
- QuintileslMS (IQVIA)
- Parexel International Corporation
- ICON plc
- PPD, Inc. (Thermo Fisher Scientific)
- LabCorp (Laboratory Corporation of America Holdings)
- Syneos Health
- wuXi AppTecLonza Group
- Piramal Pharma Solutions
- SGS SA
- Evotec SE
- CMC Biologics (Now AGC Biologics)
- Marken (A UPS Company)
- Cytovance Biologics
- Samsung Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Advanced Therapeutics Pharmaceutical Outsourcing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Contract Research Organizations (CROs)
- 2.2.3 Contract Development and Manufacturing Organizations (CDMOs)
- 2.3 Advanced Therapeutics Pharmaceutical Outsourcing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Preclinical Services
- 2.3.3 Clinical Services
- 2.3.4 Commercial Manufacturing and Packaging
- 2.4 Assumptions and Limitations
3 Advanced Therapeutics Pharmaceutical Outsourcing Breakdown Data by Type
- 3.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size by Type (2021-2026)
- 3.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Forecasted Market Size by Type (2027-2032)
4 Advanced Therapeutics Pharmaceutical Outsourcing Breakdown Data by Application
- 4.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size by Application (2021-2026)
- 4.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Perspective (2021-2032)
- 5.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Growth Trends by Region
- 5.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size by Region (2021-2026)
- 5.2.3 Advanced Therapeutics Pharmaceutical Outsourcing Forecasted Market Size by Region (2027-2032)
- 5.3 Advanced Therapeutics Pharmaceutical Outsourcing Market Dynamics
- 5.3.1 Advanced Therapeutics Pharmaceutical Outsourcing Industry Trends
- 5.3.2 Advanced Therapeutics Pharmaceutical Outsourcing Market Drivers
- 5.3.3 Advanced Therapeutics Pharmaceutical Outsourcing Market Challenges
- 5.3.4 Advanced Therapeutics Pharmaceutical Outsourcing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Advanced Therapeutics Pharmaceutical Outsourcing Players by Revenue
- 6.1.1 Global Top Advanced Therapeutics Pharmaceutical Outsourcing Players by Revenue (2021-2026)
- 6.1.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Revenue Market Share by Players (2021-2026)
- 6.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Advanced Therapeutics Pharmaceutical Outsourcing Head Office and Area Served
- 6.4 Global Advanced Therapeutics Pharmaceutical Outsourcing Players, Product Type & Application
- 6.5 Global Advanced Therapeutics Pharmaceutical Outsourcing Manufacturers Established Date
- 6.6 Global Advanced Therapeutics Pharmaceutical Outsourcing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
- 7.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 7.4 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
- 8.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 8.4 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
- 9.2 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
- 10.2 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 10.4 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
- 11.2 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Croda International Plc
- 12.1.1 Croda International Plc Company Information
- 12.1.2 Croda International Plc Business Overview
- 12.1.3 Croda International Plc Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.1.4 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.1.5 Croda International Plc Recent Developments
- 12.2 Charles River Laboratories International, Inc.
- 12.2.1 Charles River Laboratories International, Inc. Company Information
- 12.2.2 Charles River Laboratories International, Inc. Business Overview
- 12.2.3 Charles River Laboratories International, Inc. Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.2.4 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.2.5 Charles River Laboratories International, Inc. Recent Developments
- 12.3 Catalent, Inc.
- 12.3.1 Catalent, Inc. Company Information
- 12.3.2 Catalent, Inc. Business Overview
- 12.3.3 Catalent, Inc. Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.3.4 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.3.5 Catalent, Inc. Recent Developments
- 12.4 QuintileslMS (IQVIA)
- 12.4.1 QuintileslMS (IQVIA) Company Information
- 12.4.2 QuintileslMS (IQVIA) Business Overview
- 12.4.3 QuintileslMS (IQVIA) Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.4.4 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.4.5 QuintileslMS (IQVIA) Recent Developments
- 12.5 Parexel International Corporation
- 12.5.1 Parexel International Corporation Company Information
- 12.5.2 Parexel International Corporation Business Overview
- 12.5.3 Parexel International Corporation Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.5.4 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.5.5 Parexel International Corporation Recent Developments
- 12.6 ICON plc
- 12.6.1 ICON plc Company Information
- 12.6.2 ICON plc Business Overview
- 12.6.3 ICON plc Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.6.4 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.6.5 ICON plc Recent Developments
- 12.7 PPD, Inc. (Thermo Fisher Scientific)
- 12.7.1 PPD, Inc. (Thermo Fisher Scientific) Company Information
- 12.7.2 PPD, Inc. (Thermo Fisher Scientific) Business Overview
- 12.7.3 PPD, Inc. (Thermo Fisher Scientific) Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.7.4 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.7.5 PPD, Inc. (Thermo Fisher Scientific) Recent Developments
- 12.8 LabCorp (Laboratory Corporation of America Holdings)
- 12.8.1 LabCorp (Laboratory Corporation of America Holdings) Company Information
- 12.8.2 LabCorp (Laboratory Corporation of America Holdings) Business Overview
- 12.8.3 LabCorp (Laboratory Corporation of America Holdings) Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.8.4 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.8.5 LabCorp (Laboratory Corporation of America Holdings) Recent Developments
- 12.9 Syneos Health
- 12.9.1 Syneos Health Company Information
- 12.9.2 Syneos Health Business Overview
- 12.9.3 Syneos Health Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.9.4 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.9.5 Syneos Health Recent Developments
- 12.10 wuXi AppTecLonza Group
- 12.10.1 wuXi AppTecLonza Group Company Information
- 12.10.2 wuXi AppTecLonza Group Business Overview
- 12.10.3 wuXi AppTecLonza Group Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.10.4 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.10.5 wuXi AppTecLonza Group Recent Developments
- 12.11 Piramal Pharma Solutions
- 12.11.1 Piramal Pharma Solutions Company Information
- 12.11.2 Piramal Pharma Solutions Business Overview
- 12.11.3 Piramal Pharma Solutions Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.11.4 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.11.5 Piramal Pharma Solutions Recent Developments
- 12.12 SGS SA
- 12.12.1 SGS SA Company Information
- 12.12.2 SGS SA Business Overview
- 12.12.3 SGS SA Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.12.4 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.12.5 SGS SA Recent Developments
- 12.13 Evotec SE
- 12.13.1 Evotec SE Company Information
- 12.13.2 Evotec SE Business Overview
- 12.13.3 Evotec SE Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.13.4 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.13.5 Evotec SE Recent Developments
- 12.14 CMC Biologics (Now AGC Biologics)
- 12.14.1 CMC Biologics (Now AGC Biologics) Company Information
- 12.14.2 CMC Biologics (Now AGC Biologics) Business Overview
- 12.14.3 CMC Biologics (Now AGC Biologics) Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.14.4 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.14.5 CMC Biologics (Now AGC Biologics) Recent Developments
- 12.15 Marken (A UPS Company)
- 12.15.1 Marken (A UPS Company) Company Information
- 12.15.2 Marken (A UPS Company) Business Overview
- 12.15.3 Marken (A UPS Company) Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.15.4 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.15.5 Marken (A UPS Company) Recent Developments
- 12.16 Cytovance Biologics
- 12.16.1 Cytovance Biologics Company Information
- 12.16.2 Cytovance Biologics Business Overview
- 12.16.3 Cytovance Biologics Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.16.4 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.16.5 Cytovance Biologics Recent Developments
- 12.17 Samsung Biologics
- 12.17.1 Samsung Biologics Company Information
- 12.17.2 Samsung Biologics Business Overview
- 12.17.3 Samsung Biologics Revenue in Advanced Therapeutics Pharmaceutical Outsourcing Business (2021-2026)
- 12.17.4 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 12.17.5 Samsung Biologics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst